Abbott India informs about disclosure

01 Aug 2025 Evaluate
In the matter of compounding application filed by the Company with the Reserve Bank of India (RBI) for having foreign investment in excess of prescribed sectoral cap, Abbott India has informed that the Company has received Compounding Order dated July 31, 2025, from the Foreign Exchange Department of RBI directing the Company to pay compounding amount of Rs 2,00,000, concluding the ongoing compounding process. The Company shall be depositing the compounding amount in accordance with the Order. The closure of the compounding process will now enable the Company to receive investment from foreign institutional investors up to the prescribed limit. The disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Circular on disclosure of material events/information (SEBI Circular SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023), with respect to the order is enclosed as Annexure A. 

The above information is a part of company’s filings submitted to BSE.




Abbott India Share Price

28869.35 42.50 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×